TTK Healthcare Limited (NSE:TTKHLTCARE)

Market Cap	13.14B -26.3%
Revenue (ttm)	8.57B +7.0%
Net Income	656.81M -19.6%
EPS	46.48 -19.6%
Shares Out	n/a
PE Ratio	20.01
Forward PE	n/a
Dividend	10.00 (1.12%)
Ex-Dividend Date	Jul 17, 2026

Volume	15,990
Open	883.35
Previous Close	883.35
Day's Range	875.35 - 964.00
52-Week Range	735.00 - 1,398.90
Beta	0.27
Analysts	Strong Buy
Price Target	1,020.00 (+9.75%)
Earnings Date	May 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1928
• Employees: 1,339
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TTKHLTCARE

Financial Performance

In fiscal year 2026, TTK Healthcare's revenue was 8.57 billion, an increase of 6.96% compared to the previous year's 8.01 billion. Earnings were 656.81 million, a decrease of -19.57%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error